Benzinga | Oct 1, 2021 04:08PM EDT

CTI BioPharma Announces Topline Data From Final Analysis Of PRE-VENT Clinical Trial Evaluating Pacritinib As Treatment For Severe COVID-19

https://www.prnewswire.com/news-releases/cti-biopharma-announces-topline-data-from-final-analysis-of-the-pre-vent-clinical-trial-evaluating-pacritinib-as-a-treatment-for-severe-covid-19-301390078.html